Enrique Samper Rodriguez
Vorstandsvorsitzender bei NIMGenetics Genómica y Medicina SL
Aktive Positionen von Enrique Samper Rodriguez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | Vorstandsvorsitzender | 01.01.2008 | - |
Gründer | 01.01.2008 | - | |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Enrique Samper Rodriguez
Statistik
International
Spanien | 2 |
Schweiz | 2 |
Operativ
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | Health Technology |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Commercial Services |